Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 17 April 2026 - 9:18

Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/teizeild

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters